Additional Information

Description

Spravato 56 mg Dose Kit 2x28 mL 3N is a nasal spray formulation of esketamine, indicated for treatment-resistant depression in adults. Esketamine, a rapidly acting N-methyl-D-aspartate (NMDA) receptor antagonist, provides fast-acting relief for patients who have not responded adequately to traditional antidepressant treatments. By modulating glutamate, a key neurotransmitter in the brain, esketamine is believed to restore synaptic connections and enhance neural plasticity.

Each kit contains two 28 mL bottles of esketamine solution, with each spray delivering 56 mg of esketamine per dose. The nasal spray is administered under medical supervision in a certified healthcare facility due to the potential for side effects and the need for monitoring.

Spravato is indicated for patients who have failed at least two different antidepressant treatments for major depressive disorder. It is often prescribed as part of a comprehensive treatment plan that includes oral antidepressants. Common side effects of Spravato include dizziness, dissociation, and increased blood pressure.